logo
logo
Sign in

The medical use of unfractionated heparin is to treat heart disease by lowering its molecular weight

avatar
Vivek Vishwakarma
The medical use of unfractionated heparin is to treat heart disease by lowering its molecular weight

Hemophilia A and B are treated with unfractionated heparin, a blood product found primarily in horses. Heparin that has not been fractionated is generally referred to as unfractionated heparin. It's usually a complicated glycosaminoglycan that's difficult to break down as a blood product. It is, however, broken down into numerous molecules in this situation. In patients with haematological disorders, unfractionated heparin is frequently used to treat sickle cell disease and anaemia. The activity of neutrophils, the Thymus Gland, and monocytes has been demonstrated to be increased by unfractionated heparin (UVH). It has been demonstrated to protect sickle cell disease patients against infections. It also appears to be effective in lowering the severity of bleeding and reducing the risk of thrombosis in acute-care settings.

Because of its anticoagulant activity, Unfractionated heparin is considered the superior alternative of the synthetic active components in its pure condition. In individuals with severe atherosclerotic disease, it successfully lowers blood clots and inhibits the formation of Deep Vein Thrombosis (DVT). In people with moderate atherosclerosis, however, it has fewer effects. Heparin, which is unfractionated, is used as a blood thinner and a vasodilator. It has also been demonstrated to be beneficial in patients with moderate benign intracranial hypertension and those who have had the anticoagulant action of heparin surgically implanted.

Read More: https://bit.ly/3m8XqJa

collect
0
avatar
Vivek Vishwakarma
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more